Clinical trial
Extracellular Vesicles As Non-Invasive Biomarkers for Huntington Disease Progression and Huntingtin Lowering Therapy
NCT06082713 is registered in ClinicalTrials.gov with University of Central Florida as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Extracellular Vesicles As Non-Invasive Biomarkers for Huntington Disease Progression and Huntingtin Lowering Therapy
- Lead sponsor
- University of Central Florida
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 25, 2023
- Completion date
- November 30, 2031
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.